United Kingdom news - the latest biotech news from Labiotech.eu

Home United Kingdom Page 63

Latest Posts

News and Trends 1 Jun 2016

EMA approves Groundbreaking Gene Therapy for Super Rare ‘Bubble Baby’ Disease

GSK, Fondazione Telethon and Ospedale San Raffaele have announced that the EMA has approved Strimvelis for a super rare immunodeficiency disease in Children. Following 20 years of research at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Italy, this is the news patients have been waiting for. Strimvelis is the first ex vivo stem cell gene […]

June 1, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 31 May 2016

UK Immunotherapy against Grass Allergies moves on to Phase III Trials

Circassia is beginning a Phase III trial for its short-course immunotherapy for grass allergies. This common type of allergy can significantly impact the life quality of patients. Circassia is based in Oxford (UK) and was part of 2014’s record Biotech IPOs – raising a whopping €268M. It focuses on respiratory diseases, such as asthma and allergies. Its […]

May 31, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 26 May 2016

GSK teams up with US Money to found new Biotech

GSK and Avalon Ventures are having success with the Biotechs created under their collaboration. Sitari Pharmaceuticals and Silarus Therapeutics have achieved their first milestones, and there’s a 8th Biotech in the making. As part of its innovation hunting in the US, English big Pharma GSK had struck a collaboration with Avalon Ventures and formed an ‘undercover incubator’ of sorts. […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 23 May 2016

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

Researchers from University of Cambridge and the Wellcome Trust Sanger Institute have discovered that Ebola can still be transmitted through sex and breastfeeding after quarantine – causing ‘flare-ups’ even though the epidemic has ended. Without effective vaccines or treatments for Ebola infection, the 2014’s outbreak in West Africa was contained due to public health measures. These […]

May 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 19 May 2016

DIY Biology catches on with the UK’s first BioHackacthon

The hackathon phenomena is knocking on biology’s door. The first UK Biohackathon will be held at the University of Cambridge in June, to learn and create with SynBio. Hackathons are massively popular events in computer programming, joining people during a short period to create a hands-on project. The concept has now spread to biology – more […]

May 19, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 18 May 2016

New UK Biotech could treat Diabetes with Lab-grown Cells

Islexa is the new baby of Catapult and the University of Aberdeen, which will be developing laboratory grown islets. This could replace insulin production in patients with type 1 diabetes. One of the coolest Biotechs in London, Catapult has joined the University of Aberdeen to create a new Biotech that could revolutionize treatment of type […]

May 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

News and Trends 12 May 2016

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

OxStem’s strategy for stem cells therapy inside the body could have a big impact in regenerative medicine – and it has raised €21.4M, a record for a UK spin-out. A spin-out of Oxford University, OxStem is developing cell programming therapies that could treat a range of usually age-related conditions – dementia, heart failure, macular degeneration, […]

May 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 10 May 2016

Life Sciences VC gets €204M in its Biggest Fundraiser Ever

MVM Capital has raised its fourth and largest funding round. It now has an additional €204M to invest in healthcare in the US and Europe. With offices in Boston and London, MVM Capital is an important VC in the healthcare sector – from biotechnology to medical devices. Its biggest success story is perhaps Heptares, a […]

May 10, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 10 May 2016

This UK Company told us how they Optimise Drug Development and turn a Profit

Drug development is complex, requiring a high level of many different skills as well as an insane amount of cash to put it on the market. Having an innovative business model can be one solution to make it affordable. That is what Ergomed, a profitable UK company is doing: combining Clinical Research Organisation (CRO) services and […]

May 10, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 10 May 2016

British Researchers Stack Bacteria to Turn Urine into Electricity

Researchers from Bristol in the UK developed a new design of microbial fuel cells (MFCs), a more efficient way to use wastewater to produce electricity. Want to power your smartphone with your pee? Biotechnology has been diligently working on the idea for decades now, with microbial fuel cells (MFCs). A fuel cell is a technology that can […]

May 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 May 2016

UK Biopharma joins Allergy race with good Phase II results for Hayfever

Allergy Therapeutics has gotten positive results for its phase II trial for birch pollen allergy – another win for their Pollinex platform. Based near Brighton (UK), Allergy Therapeutics has around 420 employees and has a market cap of €1.96M (£1.53M). Its focus is novel immunotherapies, with new technology for improving delivery and adjuvants – agents […]

May 9, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 9 May 2016

Universal CAR-T given to Second baby with aggressive Leukemia

Once again, the French biotech Cellectis has hit headlines after having treated a second infant suffering from an aggressive form of Leukemia with their UCART19 therapy. Also based at the famous Great Ormond Street Hospital (GOSH) in London, another child has been treated with the first ever Universal CAR-T cell therapy. The child in question […]

May 9, 2016 - 2 minutesmins - By Dani Bancroft

ADVERTISEMENT